Why the study?
Does oral pseudoephedrine and nasal phenylephrine improve vasopressor-dependent hypotension in a patient with a C1 spinal cord lesion?
Does oral pseudoephedrine and nasal phenylephrine improve vasopressor-dependent hypotension in a patient with a C1 spinal cord lesion?
Oral pseudoephedrine and nasal phenylephrine may be effective in weaning patients with high cervical spinal cord injuries from intravenous vasopressors.
May facilitate vasopressor weaning in C1 tetraplegia; hypothesis-generating and requires prospective trials before adoption.
A complete traumatic C1 spinal cord lesion leads to bradycardia and temporary hypotension until fluid administration can restore blood volume and pressure to the autosympathectomized capacitance vessels. In spite of adequate volume status, however, our patient required intravenous pressor agents to maintain adequate arterial and central venous pressure several weeks after injury. Using oral pseudoephedrine and occasional nasal phenylephrine, intravenous lines could be removed with maintenance of arterial pressure and resolution of bradycardia.
No takes yet. Share an insight, caveat, or question.
Shapiro et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: